Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Bergentoft Pharma Consulting AB

Closing information (x1000 SEK)

Closing information 2024/12 2023/12 2022/12
Turnover 6 More Arrow 1,984 More Arrow 2,054
Financial expenses 15 Less Arrow 8 Less Arrow 0
Earnings before taxes -79 More Arrow 1,734 Less Arrow 1,266
EBITDA -162 More Arrow 1,718 Less Arrow 1,266
Total assets 3,174 More Arrow 3,979 Less Arrow 2,938
Current assets 2,064 More Arrow 3,024 Less Arrow 1,938
Current liabilities 105 More Arrow 626 More Arrow 766
Equity capital 2,826 More Arrow 3,103 Less Arrow 2,018
- share capital 50 Equal arrow 50 Equal arrow 50
Employees (average) 1 More Arrow 2 Less Arrow 1

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 89.0% Less Arrow 78.0% Less Arrow 68.7%
Turnover per employee 6 More Arrow 992 More Arrow 2,054
Profit as a percentage of turnover -1316.7% More Arrow 87.4% Less Arrow 61.6%
Return on assets (ROA) -2.0% More Arrow 43.8% Less Arrow 43.1%
Current ratio 1965.7% Less Arrow 483.1% Less Arrow 253.0%
Return on equity (ROE) -2.8% More Arrow 55.9% More Arrow 62.7%
Change turnover -1,978 More Arrow -70 More Arrow 878
Change turnover % -100% More Arrow -3% More Arrow 75%
Chg. No. of employees -1 More Arrow 1 Less Arrow 0
Chg. No. of employees % -50% More Arrow 100% Less Arrow 0%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.